Clobquin F Cream contains Clobetasol 0.05% w/w, a potent corticosteroid used to treat inflammation, redness, and itching, and Fusidic Acid 2% w/w, a topical antibiotic effective against gram-positive bacterial infections. Together, they provide a dual therapeutic action for skin irritation associated with secondary bacterial infections.
This combination helps in reducing symptoms of eczema, dermatitis, psoriasis flare-ups, allergic skin reactions, impetigo, and infected atopic lesions. The steroid reduces inflammation and swelling, while the antibiotic controls bacterial growth, ensuring faster recovery and reduced recurrence.
Clobquin F Cream belongs to the dermatology, anti-inflammatory, and anti-infective segment and is widely recommended by dermatologists for managing mixed skin conditions requiring both anti-inflammatory and antibacterial therapy.
For PCD pharma franchise associates, retailers, and exporters, Clobquin F Cream provides strong business demand due to its regular prescriptions in dermatology care. The product is available for bulk orders, PCD franchise rights, institutional supply, third-party manufacturing, and export worldwide, ensuring attractive profit margins and continuous demand.